Initial Therapy with Glucocorticoids plus Obinutuzumab for Pediatric Steroid-Sensitive Nephrotic Syndrome (ChiCTR) - Oct 16, 2026 - P=N/A | N=40 | Not yet recruiting | Sponsor: Capital Medical University Affiliated Capital Institute of Pediatrics; Capital Medical University Affiliated Capital Institute of Pediatrics
New trial • Glomerulonephritis • Nephrology • Pediatrics • Renal Disease
|